Physician profile
Jack Miletic
NPI 1982872990
$1,323.61
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $504 · 2021: $537 · 2022: $253 · 2023: $30.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $322.29 | 2020-2022 | |
| Stimwave Technologies Incorporated | $191.73 | 2021 | |
| Medtronic USA, INC. | $155.93 | 2020 | |
| Collegium Pharmaceutical, INC. | $104.71 | 2020-2021 | |
| Depuy Synthes Sales INC. | $100.99 | 2020-2023 | Orthovisc |
| Medtronic, INC. | $63.10 | 2021-2022 | |
| Abbott Laboratories | $51.01 | 2022 | |
| Ibsa Pharma INC. | $39.61 | 2021 | |
| Baudax Bio INC. | $38.35 | 2020 | |
| Nalu Medical, INC. | $37.07 | 2021 | |
| Spinal Simplicity, LLC | $35.93 | 2022 | |
| Biodelivery Sciences International, INC. | $32.70 | 2020-2021 | |
| Eisai INC. | $32.38 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $24.83 | 2021 | |
| Zimmer Biomet Holdings, INC. | $20.29 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.94 | 2020 | |
| Redhill Biopharma INC. | $15.59 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.12 | 2021 | |
| Hikma Pharmaceuticals USA | $13.53 | 2021 | |
| Nevro Corp. | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Miletic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.